96 related articles for article (PubMed ID: 16227087)
1. Tetramer analysis of human autoreactive CD4-positive T cells.
Nepom GT
Adv Immunol; 2005; 88():51-71. PubMed ID: 16227087
[TBL] [Abstract][Full Text] [Related]
2. Low-avidity recognition by CD4+ T cells directed to self-antigens.
Gebe JA; Falk BA; Rock KA; Kochik SA; Heninger AK; Reijonen H; Kwok WW; Nepom GT
Eur J Immunol; 2003 May; 33(5):1409-17. PubMed ID: 12731068
[TBL] [Abstract][Full Text] [Related]
3. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
5. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
[TBL] [Abstract][Full Text] [Related]
6. Regulation of autoreactive B cells: checkpoints and activation.
Ding C; Yan J
Arch Immunol Ther Exp (Warsz); 2007; 55(2):83-9. PubMed ID: 17347802
[TBL] [Abstract][Full Text] [Related]
7. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G
Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991
[TBL] [Abstract][Full Text] [Related]
8. CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions.
Bruder D; Westendorf AM; Geffers R; Gruber AD; Gereke M; Enelow RI; Buer J
Am J Respir Crit Care Med; 2004 Dec; 170(11):1145-52. PubMed ID: 15306530
[TBL] [Abstract][Full Text] [Related]
9. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
Markovic-Plese S
Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
[TBL] [Abstract][Full Text] [Related]
10. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
[TBL] [Abstract][Full Text] [Related]
11. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
12. CD8+ suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65.
James EA; Kwok WW
Eur J Immunol; 2007 Jan; 37(1):78-86. PubMed ID: 17163450
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells.
Westendorf AM; Fleissner D; Deppenmeier S; Gruber AD; Bruder D; Hansen W; Liblau R; Buer J
Gastroenterology; 2006 Aug; 131(2):510-24. PubMed ID: 16890605
[TBL] [Abstract][Full Text] [Related]
14. Restimulation of resting autoreactive T cells by Schwann cells in vitro.
Lilje O; Armati PJ
Exp Mol Pathol; 1999 Dec; 67(3):164-74. PubMed ID: 10600399
[TBL] [Abstract][Full Text] [Related]
15. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
[TBL] [Abstract][Full Text] [Related]
16. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
Moro M; Cecconi V; Martinoli C; Dallegno E; Giabbai B; Degano M; Glaichenhaus N; Protti MP; Dellabona P; Casorati G
BMC Immunol; 2005 Dec; 6():24. PubMed ID: 16329759
[TBL] [Abstract][Full Text] [Related]
17. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.
Lutz MB; Kurts C
Eur J Immunol; 2009 Sep; 39(9):2325-30. PubMed ID: 19701895
[TBL] [Abstract][Full Text] [Related]
18. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
20. Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.
Godefroy E; Wang Y; Souleimanian NE; Scotto L; Stevanovic S; Chen YT; Valmori D; Ayyoub M
Cancer Immunol Immunother; 2007 Aug; 56(8):1183-92. PubMed ID: 17186289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
